Indegene Limited's Board of Directors has approved an investment of up to €5.2 million in Indegene Ireland Limited, its wholly-owned subsidiary, to support capital expenditure aimed at expanding its operations. The approval also includes the re-appointment of Mr. Madhwesh K as Secretarial Auditor for FY 2024-25 and a recommendation for M/s Madhwesh Prathap and Associates for a five-year term starting FY 2025-26, pending shareholder approval. The investment could bolster growth prospects, reflecting strategic focus on enhancing capabilities in the healthcare sector. This move may foster a positive outlook among investors, signaling commitment to expansion and operational efficiency.